Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 115 articles:
HTML format



Single Articles


    July 2022
  1. CANNELLA R
    Editorial Comment: LI-RADS Provides High Accuracy for Liver Transplant Eligibility in High-Risk Patients.
    AJR Am J Roentgenol. 2022;219:96.
    PubMed    


  2. HUBER AT, Obmann V
    Beyond the AJR: Prognostic Value of a Single Baseline Liver Stiffness Measurement by MR Elastography in Patients With Chronic Liver Disease.
    AJR Am J Roentgenol. 2022;219:169.
    PubMed    


    June 2022
  3. DILLMAN JR, Thapaliya S, Tkach JA, Trout AT, et al
    Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison to MRI Proton-Density Fat Fraction as Reference Standard.
    AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27878.
    PubMed     Abstract available


  4. BASTAWROUS S
    Editorial Comment: Factors Impacting Ultrasound LI-RADS Visualization Scores-Optimizing Future Quality Assurance and Standards.
    AJR Am J Roentgenol. 2022;218:1020.
    PubMed    


    May 2022
  5. HULL NC
    Editorial Comment: Hepatocellular Carcinoma Screening Guidelines Are Needed in Children With Predisposing Conditions.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27975.
    PubMed    


  6. DASTMALCHIAN S, Aryafar H, Tavri S
    Intravascular Ultrasound Guidance for Transjugular Intrahepatic Portosystemic Shunt Procedures: A Review.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27626.
    PubMed     Abstract available


  7. KIM SH, Navot B, Guniganti P, Gavlin A, et al
    Liver Transplant for Non-Hepatocellular Malignancies: A Review for Radiologists.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27783.
    PubMed     Abstract available


  8. REES MA, Schooler GR, Chavhan GB, Towbin AJ, et al
    Imaging Features of Hepatocellular Carcinoma in Children With and Without Underlying Risk Factors.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27600.
    PubMed     Abstract available


  9. LUNA A
    Editorial Comment: Integrated Diagnosis of Hepatocellular Carcinoma-An Opportunity for Abdominal Radiologists.
    AJR Am J Roentgenol. 2022 May 4:12. doi: 10.2214/AJR.22.27611.
    PubMed    


  10. CANNELLA R, Lewis S, da Fonseca L, Ronot M, et al
    Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27633.
    PubMed     Abstract available


    April 2022
  11. LI L, Zheng W, Wang J, Han J, et al
    Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.22.27521.
    PubMed     Abstract available


  12. WANG X, Guo Y, Yang L, Luo X, et al
    Use of an Intrahepatic Arterial Targeting Wire for Guiding Portal Vein Puncture During TIPS Creation in Patients With Obliterative Portal Vein Thrombosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27675.
    PubMed     Abstract available


  13. KURTZ D, Wachsberg RH
    Factitious Nodularity of the Anterior Liver Surface on Prone Abdominal CT: A Potential Mimic of Cirrhosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27669.
    PubMed    


  14. FETZER DT
    Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes.
    AJR Am J Roentgenol. 2022;218:761.
    PubMed    


    March 2022
  15. YOUNG S
    Editorial Comment: Echocardiography-Should It Be Routine Before Elective TIPS?
    AJR Am J Roentgenol. 2022 Mar 2. doi: 10.2214/AJR.22.27580.
    PubMed    


  16. TANG A
    Editorial Comment: LI-RADS LR-2 and LR-3 Observations-Benign or Not Benign?
    AJR Am J Roentgenol. 2022;218:471.
    PubMed    


    February 2022
  17. ALI A, Sarwar A, Patwardhan VR, Fraiche AM, et al
    Echocardiographic and Other Preprocedural Predictors of Heart Failure After TIPS Placement in Patients With Cirrhosis: A Single-Center 15-Year Analysis.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26947.
    PubMed     Abstract available


  18. LOY LM, Low HM, Choi JY, Rhee HJ, et al
    Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26982.
    PubMed     Abstract available


  19. BAE JS, Lee DH, Lee SM, Suh KS, et al
    Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplantation According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27186.
    PubMed     Abstract available


  20. YANG C, Chen Q, Zhou C, Liu J, et al
    FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27301.
    PubMed     Abstract available


  21. MELLNICK VM
    Editorial Comment: Increased liver lesion visualization on CT without increased cost.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27391.
    PubMed    


  22. GEE MS
    Editorial Comment: Novel Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Young Patients With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27453.
    PubMed    


    January 2022
  23. MCCRARY J, Trout AT, Mahalingam N, Singh R, et al
    Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27204.
    PubMed     Abstract available


  24. CHO KJ
    Editorial Comment: Bland Hepatic Artery Embolization (HAE) for Hepatic Malignancy-Can Bland HAE be Performed on an Outpatient Basis?
    AJR Am J Roentgenol. 2022 Jan 19. doi: 10.2214/AJR.22.27384.
    PubMed    


  25. BONGERS MN, Walter S, Fritz J, Bier G, et al
    Interindividual Comparison of Frequency-Selective Nonlinear Blending to Conventional CT for Detection of Focal Liver Lesions Using MRI as the Reference Standard.
    AJR Am J Roentgenol. 2022 Jan 12. doi: 10.2214/AJR.21.26922.
    PubMed     Abstract available


  26. RMILAH AA, Qrareya MN, Fleming C, Alkurashi AK, et al
    Association of Cirrhosis and Other Patient and Procedural Characteristics With Postembolization Syndrome after Bland Hepatic Artery Embolization for Hepatic Malignancy.
    AJR Am J Roentgenol. 2022 Jan 5. doi: 10.2214/AJR.21.26806.
    PubMed     Abstract available


  27. DILLMAN JR, Franck MD, Gandhi D, Pednekar AS, et al
    Agreement Between Automated and Clinically Reported Manual ROI-Based MR Elastography Liver Stiffness Measurements in Children and Young Adults.
    AJR Am J Roentgenol. 2022;218:163-164.
    PubMed     Abstract available


    December 2021
  28. XIAN MF, Huang Y, Xie WX, Pan KM, et al
    LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison with Current LI-RADS Criteria.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26837.
    PubMed     Abstract available


  29. LIU PS
    Editorial Comment: Is Quantitative CT Fat Fraction Ready For Prime Time?
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27184.
    PubMed    


  30. FETZER DT, Browning T, Xi Y, Yokoo T, et al
    Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26735.
    PubMed     Abstract available


  31. SCHIMA W
    Editorial Comment: Which MRI Contrast Agent for Hepatocellular Carcinoma Diagnosis in LI-RADS? The Fog is Lifting.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.27171.
    PubMed    


    November 2021
  32. GUO Z, Blake GM, Graffy PM, Sandfort V, et al
    Hepatic Steatosis: CT-based Prevalence in Adults in China and the United States and Associations with Age, Sex, and Body Mass Index.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26728.
    PubMed     Abstract available


  33. RONG D, He B, Tang W, Xie S, et al
    Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26818.
    PubMed     Abstract available


    October 2021
  34. HAO F, Eghbalieh N, So A, Lee EW, et al
    Hepatic Plexus Nerve Block for Microwave Ablation of Hepatic Tumors.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26779.
    PubMed     Abstract available


  35. STRUYCKEN L, Patel M, Kuo P, Hennemeyer C, et al
    Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26663.
    PubMed     Abstract available


  36. CHERNYAK V
    Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable HCC After Locoregional Treatment.
    AJR Am J Roentgenol. 2021 Oct 20. doi: 10.2214/AJR.21.26949.
    PubMed    


  37. CHERNYAK V, van der Pol CB, Vernuccio F, Yoshimitsu K, et al
    The Global Reading Room: Imaging Detection of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26909.
    PubMed    


  38. RANATHUNGA D, Osman H, Islam N, McInnes MD, et al
    Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk for Hepatocellular Carcinoma: A Retrospective Study.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26376.
    PubMed     Abstract available


  39. LIU J, Ma J, Yang C, Ye T, et al
    Reply to "Factors in Spleen Size After TIPS Placement".
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  40. GEMERY JM, Munger DP, Hoffer EK
    Factors in Spleen Size After TIPS Placement.
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  41. FERRAIOLI G
    Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease".
    AJR Am J Roentgenol. 2021;217:1012.
    PubMed    


    September 2021
  42. DOHARE N, Madhusudhan KS, Malik R, Das P, et al
    Utility of Hepatic 2D Shear-Wave Elastography in Monitoring Response to Image-Guided Intervention in Children With Chronic Budd-Chiari Syndrome: A Prospective Study.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26547.
    PubMed     Abstract available


  43. KIM YY, Kim MJ, Yoon JK, Shin J, et al
    Incorporation of Ancillary MRI Features into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26677.
    PubMed     Abstract available


  44. REIZINE E, Chalaye J, Mule S, Regnault H, et al
    Utility of Early Posttreatment PET/CT Evaluation Using FDG or (18)F-FCH to Predict Response to (90)Y Radioembolization in Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26485.
    PubMed     Abstract available


    August 2021
  45. SHARBIDRE KG
    Editorial Comment: Recurrence of Hepatocellular Carcinoma in Liver Transplants-Microvascular Invasion and Pathologic Staging of the Explant Liver.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26681.
    PubMed    


  46. CUNHA GM, Hosseini M, Furlan A, Fowler K, et al
    Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26436.
    PubMed     Abstract available


    July 2021
  47. SEVCO TJ, Masch WR, Maturen KE, Mendiratta-Lala M, et al
    Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    AJR Am J Roentgenol. 2021 Jul 14:1-7. doi: 10.2214/AJR.20.23447.
    PubMed     Abstract available


  48. PAUL RK, Vazirani R, McDermott JC, Kliewer MA, et al
    Identification of the Most Important Subset of Doppler, Laboratory, and Clinical Parameters for Serial TIPS Evaluation.
    AJR Am J Roentgenol. 2021;217:164-171.
    PubMed     Abstract available


    June 2021
  49. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    PubMed     Abstract available


  50. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    PubMed     Abstract available


    May 2021
  51. RIDDELL AM, Torkzad MR, Koh DM
    Reply to "Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases".
    AJR Am J Roentgenol. 2021 May 19:W1-W2. doi: 10.2214/AJR.21.25747.
    PubMed    


  52. GRANATA V, Fusco R, Petrillo A
    Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 May 19:W1. doi: 10.2214/AJR.21.25652.
    PubMed    


  53. MALONE CD
    Editorial Comment on "Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement".
    AJR Am J Roentgenol. 2021;216:1299.
    PubMed    


    April 2021
  54. ROBBINS AJ, Ritter S, Markese M, Skube ME, et al
    Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant.
    AJR Am J Roentgenol. 2021 Apr 28:1-7. doi: 10.2214/AJR.20.23303.
    PubMed     Abstract available


  55. CHAVHAN GB, Yoo SJ, Lam CZ, Khanna G, et al
    Abdominal Imaging of Children and Young Adults With Fontan Circulation: Pathophysiology and Surveillance.
    AJR Am J Roentgenol. 2021 Apr 28:1-11. doi: 10.2214/AJR.20.23404.
    PubMed     Abstract available


  56. SQUIRES JH, McCarville MB
    Contrast-Enhanced Ultrasound in Children: Implementation and Key Diagnostic Applications.
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.25713.
    PubMed     Abstract available


  57. KIM B, Won JH, Kim J, Kwon Y, et al
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    AJR Am J Roentgenol. 2021 Apr 14:1-8. doi: 10.2214/AJR.20.23213.
    PubMed     Abstract available


  58. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    PubMed     Abstract available


  59. FERRAIOLI G, Barr RG
    Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
    AJR Am J Roentgenol. 2021;216:W14.
    PubMed    


  60. CORNMAN-HOMONOFF J, Madoff DC
    Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".
    AJR Am J Roentgenol. 2021;216:878.
    PubMed    


    March 2021
  61. YOUNG S, Cam I, Gencturk M
    Reply to "Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome".
    AJR Am J Roentgenol. 2021 Mar 24:W1. doi: 10.2214/AJR.20.24769.
    PubMed    


  62. LUDWIG DR, Fraum TJ, Ballard DH, Narra VR, et al
    Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI.
    AJR Am J Roentgenol. 2021 Mar 17:1-11. doi: 10.2214/AJR.20.23099.
    PubMed     Abstract available


  63. MADHUSUDHAN KS, Sharma S
    Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome.
    AJR Am J Roentgenol. 2021 Mar 17:W1. doi: 10.2214/AJR.20.24556.
    PubMed    


  64. SARWAR A, Esparaz AM, Chakrala N, Mangano M, et al
    Efficacy of TIPS Reduction for Refractory Hepatic Encephalopathy, Right Heart Failure, and Liver Dysfunction.
    AJR Am J Roentgenol. 2021 Mar 11:1-6. doi: 10.2214/AJR.19.22497.
    PubMed     Abstract available


  65. LOKKEN RP, Kerlan RK , Jr, Chung YC, Chen YF, et al
    Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Mar 11:1-8. doi: 10.2214/AJR.20.23478.
    PubMed     Abstract available


  66. WANG Y, Liang W
    Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2021;216:W12.
    PubMed    


  67. HOMAYOUNIEH F, Kalra MK
    Reply to "Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions".
    AJR Am J Roentgenol. 2021;216:W13.
    PubMed    


  68. LEE GM, Stowell JT, Pope K, Carter BW, et al
    Lymphatic Pathways of the Thorax: Predictable Patterns of Spread.
    AJR Am J Roentgenol. 2021;216:649-658.
    PubMed     Abstract available


    February 2021
  69. WU V, Li MD, Goodwin JS, Wehrenberg-Klee EP, et al
    Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location.
    AJR Am J Roentgenol. 2021 Feb 17. doi: 10.2214/AJR.20.25315.
    PubMed     Abstract available


  70. RIEDESEL EL
    Editorial Comment: Liver Fat Quantification by Ultrasound-Potential to Change Diagnosis and Management of Pediatric NAFLD.
    AJR Am J Roentgenol. 2021 Feb 10. doi: 10.2214/AJR.21.25594.
    PubMed    


  71. VAN DER POL CB, Dhindsa K, Shergill R, Zha N, et al
    MRI Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Impact of and Reduction in Ancillary Features.
    AJR Am J Roentgenol. 2021 Feb 3:1-8. doi: 10.2214/AJR.20.23031.
    PubMed     Abstract available


  72. MARKS RM, Masch WR, Chernyak V
    LI-RADS: Past, Present, and Future, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2021;216:295-304.
    PubMed     Abstract available


    January 2021
  73. TORKZAD MR, Riddell AM, Chau I, Cunningham D, et al
    Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 Jan 27:1-8. doi: 10.2214/AJR.20.22854.
    PubMed     Abstract available


  74. LUBNER MG, Graffy PM, Said A, Watson R, et al
    Utility of Multiparametric CT for Identification of High-Risk NAFLD.
    AJR Am J Roentgenol. 2021 Jan 21:1-10. doi: 10.2214/AJR.20.22842.
    PubMed     Abstract available


  75. BUROS C, Furlan A
    Beyond the AJR: "Magnetic Resonance Elastography versus Transient Elastography in the Prediction of Complications after Resection for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2021 Jan 20. doi: 10.2214/AJR.21.25458.
    PubMed    


  76. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Reply to "Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index".
    AJR Am J Roentgenol. 2021;216:W2.
    PubMed    


  77. LIZARAZO DA, Romero J, Gonzalez-Gomez S
    Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index.
    AJR Am J Roentgenol. 2021;216:W1.
    PubMed    


    December 2020
  78. BOYUM JH, Sheedy SP, Graham RP, Olson JT, et al
    Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI.
    AJR Am J Roentgenol. 2020 Dec 23:1-9. doi: 10.2214/AJR.20.22768.
    PubMed     Abstract available


  79. KINNEY TB
    Editorial Comment: A Cautionary Experience with Drug-Eluting Beads Transarterial Chemoembolization for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Dec 23. doi: 10.2214/AJR.20.25284.
    PubMed    


  80. YANG Q, Cai Q, Wen H, Mao Y, et al
    The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
    AJR Am J Roentgenol. 2020 Dec 16:1-10. doi: 10.2214/AJR.20.22937.
    PubMed     Abstract available


  81. RENTON M, Kielar A
    Beyond the AJR: "Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications".
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.25188.
    PubMed    


  82. CHENG J, Qiu M, Zhang Y, Hong N, et al
    Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy.
    AJR Am J Roentgenol. 2020;215:1377-1383.
    PubMed     Abstract available


    November 2020
  83. ZHANG L, Sun JH, Ji JS, Zhong BY, et al
    Imaging Changes and Clinical Complications After Drug-Eluting Beads Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    AJR Am J Roentgenol. 2020 Nov 27. doi: 10.2214/AJR.20.24708.
    PubMed     Abstract available


    October 2020
  84. KIM YY, Choi JY, Kim SU, Lee M, et al
    MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
    AJR Am J Roentgenol. 2020 Oct 14:1-9. doi: 10.2214/AJR.20.22802.
    PubMed     Abstract available


  85. STRNAD BS, Ludwig DR, Gilcrease-Garcia B, Fraum TJ, et al
    Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump.
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24437.
    PubMed     Abstract available


  86. KEE-SAMPSON J
    Editorial Comment on "Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis".
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24849.
    PubMed    


    September 2020
  87. NABAVIZADEH N, Jahangiri Y, Rahmani R, Tomozawa Y, et al
    Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis.
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24117.
    PubMed     Abstract available


  88. BORHANI AA
    Editorial Comment on "Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard".
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24764.
    PubMed    


  89. PICKHARDT PJ, Blake GM, Graffy PM, Sandfort V, et al
    Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard.
    AJR Am J Roentgenol. 2020 Sep 16. doi: 10.2214/AJR.20.24415.
    PubMed     Abstract available


  90. MICHELL H, Johnston GP, Chopra P, Scriver GM, et al
    Cholecystostomy as an Exclusive Access to Remove Cystic, Common Hepatic, and Common Bile Duct Stones.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22469.
    PubMed     Abstract available


  91. PHAM JT, Kalantari J, Ji C, Chang JH, et al
    Quantitative CT Predictors of Portal Venous Intervention in Uncontrolled Variceal Bleeding.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22460.
    PubMed     Abstract available


  92. KIERANS AS, Song C, Gavlin A, Roudenko A, et al
    Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Sep 2:1-8. doi: 10.2214/AJR.20.22772.
    PubMed     Abstract available


  93. ANDREWS JC
    Editorial Comment on "Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding".
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24486.
    PubMed    


  94. MONTI L, Salsano M, Candusso M, Avolio AW, et al
    Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging.
    AJR Am J Roentgenol. 2020 Sep 2:1-9. doi: 10.2214/AJR.19.22057.
    PubMed     Abstract available


    August 2020
  95. WEI B, Zhang L, Tong H, Wang Z, et al
    Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding.
    AJR Am J Roentgenol. 2020 Aug 26. doi: 10.2214/AJR.20.23859.
    PubMed     Abstract available


  96. OLSON MC, Venkatesh SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Counterpoint: No, CT/MR is the Way to Go.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24252.
    PubMed    


  97. KAMAYA A, Rodgers SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Point: Yes, Ultrasound Remains First Line.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24382.
    PubMed    


  98. BORRERO R, Valencia S, Triana G
    Are Cutoff Points of Liver Fibrosis in Shear Wave Elastography Really Reliable to Determine Whether Patients Should Undergo Biopsy?
    AJR Am J Roentgenol. 2020;215:W29.
    PubMed    


    July 2020
  99. MANCHEC B, Pham E, Noor M, Pepe J, et al
    Contrast-Enhanced CT May Identify High-Risk Esophageal Varices in Patients With Cirrhosis.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22474.
    PubMed     Abstract available


  100. KIM SW, Kim YR, Choi KH, Cho EY, et al
    Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22041.
    PubMed     Abstract available


    June 2020
  101. CHU HH, Gwon DI, Kim JH, Ko GY, et al
    Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.21669.
    PubMed     Abstract available


    May 2020
  102. YOUNG S, Rostambeigi N, Golzarian J, Lim N, et al
    MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.21726.
    PubMed     Abstract available


  103. SMEREKA P, Doshi AM, Lavelle LP, Shanbhogue K, et al
    New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.22033.
    PubMed     Abstract available


  104. HOMAYOUNIEH F, Singh R, Nitiwarangkul C, Lades F, et al
    Semiautomatic Segmentation and Radiomics for Dual-Energy CT: A Pilot Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2020 May 14:1-8. doi: 10.2214/AJR.19.22164.
    PubMed     Abstract available


  105. SARWAR A, Weinstein JL, Novack V, Chakrala N, et al
    Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.
    AJR Am J Roentgenol. 2020 May 6:1-7. doi: 10.2214/AJR.19.21732.
    PubMed     Abstract available


  106. DRESCHER R, Kuhnel C, Seifert P, Guhne F, et al
    Renal and Intestinal Excretion of (90)Y and (166)Ho After Transarterial Radioembolization of Liver Tumors.
    AJR Am J Roentgenol. 2020;214:1158-1164.
    PubMed     Abstract available


    April 2020
  107. YOUNG S, Golzarain J
    Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    AJR Am J Roentgenol. 2020 Apr 7:1-12. doi: 10.2214/AJR.19.22098.
    PubMed     Abstract available


  108. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:786-791.
    PubMed     Abstract available


    March 2020
  109. WANG DC, Jang HJ, Kim TK
    Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
    AJR Am J Roentgenol. 2020 Mar 17:1-10. doi: 10.2214/AJR.19.21498.
    PubMed     Abstract available


  110. ROMBERG EK, Tang ER, Chandra T, Podberesky DJ, et al
    Applications of Pediatric Body CT Angiography: What Radiologists Need to Know.
    AJR Am J Roentgenol. 2020 Mar 4:1-12. doi: 10.2214/AJR.19.22274.
    PubMed     Abstract available


    January 2020
  111. EL-ALI AM, McCormick A, Thakrar D, Yilmaz S, et al
    Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series.
    AJR Am J Roentgenol. 2020 Jan 22:1-7. doi: 10.2214/AJR.19.22174.
    PubMed     Abstract available


  112. FURLAN A, Tublin ME, Yu L, Chopra KB, et al
    Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:W20-W26.
    PubMed     Abstract available


    October 2019
  113. KOHNO S, Isoda H, Ono A, Furuta A, et al
    Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy.
    AJR Am J Roentgenol. 2019 Oct 23:1-7. doi: 10.2214/AJR.19.21440.
    PubMed     Abstract available


  114. CONSUL N, Menias CO, Lubner MG, Katabathina VS, et al
    A Review of Viral-Related Malignancies and the Associated Imaging Findings.
    AJR Am J Roentgenol. 2019 Oct 8:1-10. doi: 10.2214/AJR.19.21357.
    PubMed     Abstract available


  115. CHUNG JW, Yu JS, Choi JM, Cho ES, et al
    Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018.
    AJR Am J Roentgenol. 2019 Oct 1:1-9. doi: 10.2214/AJR.18.20797.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: